clinical research prime

Pink Eye

  • A Phase 3, Placebo-Controlled, to Evaluate the Clinical Efficacy and Safety of Fucithalmic®, Topical Antibiotic Eye Drops, for the Treatment of Suspected Bacterial Conjunctivitis.
  • Males and Females: All Ages.
  • Participants will also receive study related treatment at no cost and will be compensated for time and travel.

Eligible participants must meet the following criteria:

  • Suspected case of bacterial conjunctivitis in at least one eye

  • Has not received ocular treatment for conjunctivitis in the last 14 days

  • Has not received ocular surgical intervention in the last six months

  • Has not used antibiotics or steroids of any kind in the last 14 days